Stock

Pulse Biosciences up 6 percent on rights (NASDAQ:PLSE)

Thinly traded micro cap Pulse Biosciences (PLSE +6.2percent ) is upward, albeit on small quantity, in response to its registration statement to get a subscription rights for that, it states, ought to return 30M at gross profits if fully dispersed.

The non-transferrable offering allows present stockholders to buy around $30M of its own common stock at a yet-to-be-determined preliminary cost.